Stan Deresinski

5.0k total citations · 1 hit paper
106 papers, 3.4k citations indexed

About

Stan Deresinski is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Stan Deresinski has authored 106 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Infectious Diseases, 51 papers in Epidemiology and 19 papers in Clinical Biochemistry. Recurrent topics in Stan Deresinski's work include Antifungal resistance and susceptibility (20 papers), Bacterial Identification and Susceptibility Testing (19 papers) and Fungal Infections and Studies (17 papers). Stan Deresinski is often cited by papers focused on Antifungal resistance and susceptibility (20 papers), Bacterial Identification and Susceptibility Testing (19 papers) and Fungal Infections and Studies (17 papers). Stan Deresinski collaborates with scholars based in United States, Canada and Netherlands. Stan Deresinski's co-authors include Elizabeth Robilotti, Benjamin A. Pinsky, Marisa Holubar, Lina Meng, Carol A. Kemper, Joel E. Gallant, Emily Mui, Richard Watkins, Jeffrey Dunn and David J. Epstein and has published in prestigious journals such as Environmental Science & Technology, Annals of Internal Medicine and Clinical Microbiology Reviews.

In The Last Decade

Stan Deresinski

91 papers receiving 3.2k citations

Hit Papers

Norovirus 2015 2026 2018 2022 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Norovirus
    2015 431 citations Stan Deresinski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stan Deresinski United States 30 1.9k 1.3k 556 523 388 106 3.4k
Sebastiaan J. van Hal Australia 35 2.1k 1.1× 1.3k 1.1× 921 1.7× 574 1.1× 429 1.1× 110 3.3k
Hiroshige Mikamo Japan 28 1.3k 0.7× 1.1k 0.9× 447 0.8× 478 0.9× 629 1.6× 235 2.9k
Stephen A. Moser United States 34 1.8k 0.9× 1.5k 1.2× 489 0.9× 424 0.8× 170 0.4× 95 3.1k
Jenny Dahl Knudsen Denmark 34 2.0k 1.1× 2.0k 1.6× 651 1.2× 377 0.7× 499 1.3× 152 3.9k
Hee‐Chang Jang South Korea 27 1.5k 0.8× 851 0.7× 326 0.6× 367 0.7× 161 0.4× 119 2.6k
Leonard B. Johnson United States 27 2.0k 1.1× 1.2k 1.0× 887 1.6× 435 0.8× 284 0.7× 90 2.7k
Audrey N. Schuetz United States 30 1.1k 0.6× 1.1k 0.9× 571 1.0× 467 0.9× 220 0.6× 121 2.9k
Gary J. Noel United States 32 1.2k 0.6× 1.1k 0.9× 384 0.7× 353 0.7× 756 1.9× 88 3.2k
Roberto Luzzati Italy 33 1.9k 1.0× 1.5k 1.2× 213 0.4× 470 0.9× 309 0.8× 158 3.9k
Frederick S. Nolte United States 32 1.5k 0.8× 2.2k 1.8× 648 1.2× 664 1.3× 123 0.3× 122 4.4k

Countries citing papers authored by Stan Deresinski

Since Specialization
Citations

This map shows the geographic impact of Stan Deresinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stan Deresinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stan Deresinski more than expected).

Fields of papers citing papers by Stan Deresinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stan Deresinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stan Deresinski. The network helps show where Stan Deresinski may publish in the future.

Co-authorship network of co-authors of Stan Deresinski

This figure shows the co-authorship network connecting the top 25 collaborators of Stan Deresinski. A scholar is included among the top collaborators of Stan Deresinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stan Deresinski. Stan Deresinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Brian, David Ha, Sarah Kim, et al.. (2024). Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience. Open Forum Infectious Diseases. 11(6). ofae103–ofae103. 1 indexed citations
2.
Meng, Lina, Emily Mui, David Ha, et al.. (2023). Comprehensive guidance for antibiotic dosing in obese adults: 2022 update. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(3). 226–246. 17 indexed citations
3.
Clements, Nicholas, et al.. (2023). Informing Building Strategies to Reduce Infectious Aerosol Transmission Risk by Integrating DNA Aerosol Tracers with Quantitative Microbial Risk Assessment. Environmental Science & Technology. 57(14). 5771–5781. 5 indexed citations
4.
Lu, Brian, David Ha, J Ferguson, et al.. (2023). 824. Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
5.
Deresinski, Stan. (2023). IN THE LITERATURE. Clinical Infectious Diseases. 76(11). i–ii. 1 indexed citations
6.
Johnson, Royce H., Ritika Sharma, Rupam Sharma, et al.. (2022). Coccidioidal Peritonitis: A Review of 17 Cases. Open Forum Infectious Diseases. 9(3). ofac017–ofac017. 3 indexed citations
7.
Meng, Lina, David Ha, Emily Mui, et al.. (2020). 1489. Safety and Performance of a Pharmacist-Driven Nasal MRSA PCR Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia at an Academic Medical Center. Open Forum Infectious Diseases. 7(Supplement_1). S746–S747.
8.
Holubar, Marisa, et al.. (2020). Bacteremia due to Methicillin-Resistant Staphylococcus aureus. Infectious Disease Clinics of North America. 34(4). 849–861. 19 indexed citations
9.
Holubar, Marisa, Lina Meng, & Stan Deresinski. (2016). Bacteremia due to Methicillin-Resistant Staphylococcus aureus. Infectious Disease Clinics of North America. 30(2). 491–507. 33 indexed citations
10.
Benedict, Kaitlin, George R. Thompson, Stan Deresinski, & Tom Chiller. (2015). Mycotic Infections Acquired outside Areas of Known Endemicity, United States. Emerging infectious diseases. 21(11). 1935–1941. 70 indexed citations
11.
Forrester, Joseph D., Carlos A. Gómez, Mike Nguyen, et al.. (2015). First case of mesh infection due to Coccidioides spp. and literature review of fungal mesh infections after hernia repair. Mycoses. 58(10). 582–587. 2 indexed citations
12.
Kullar, Ravina, George Sakoulas, Stan Deresinski, & Sebastiaan J. van Hal. (2015). When sepsis persists: a review of MRSA bacteraemia salvage therapy. Journal of Antimicrobial Chemotherapy. 71(3). 576–586. 56 indexed citations
13.
Deresinski, Stan. (2010). In the Literature. Clinical Infectious Diseases. 51(6). iii–iv. 1 indexed citations
14.
Deresinski, Stan, et al.. (2009). In the Literature. Clinical Infectious Diseases. 49(3). iii–iv. 1 indexed citations
15.
Deresinski, Stan, et al.. (2008). Reply to Cornely and Ullmann and to Jain and Pottinger. Clinical Infectious Diseases. 46(10). 1627–1628. 2 indexed citations
16.
Deresinski, Stan. (2007). Vancomycin: does it still have a role as an antistaphylococcal agent?. Expert Review of Anti-infective Therapy. 5(3). 393–401. 28 indexed citations
17.
Deresinski, Stan. (2005). Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey. Clinical Infectious Diseases. 40(4). 562–573. 344 indexed citations
18.
Gallant, Joel E. & Stan Deresinski. (2003). Tenofovir Disoproxil Fumarate. Clinical Infectious Diseases. 37(7). 944–950. 118 indexed citations
19.
Rosa, Stephen C. De, Malcolm D. Zaretsky, Mario Roederer, et al.. (2000). N‐acetylcysteine replenishes glutathione in HIV infection. European Journal of Clinical Investigation. 30(10). 915–929. 218 indexed citations
20.
Dompeling, Edward, J. Peter Donnelly, John Raemaekers, et al.. (1998). Evolution of the clinical manifestations of infection during the course of febrile neutropenia in patients with malignancy. Infection. 26(6). 349–354. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastiaan J. van Hal Breakdown of academic impact, for papers by Hiroshige Mikamo Breakdown of academic impact, for papers by Stephen A. Moser Breakdown of academic impact, for papers by Jenny Dahl Knudsen Breakdown of academic impact, for papers by Hee‐Chang Jang Breakdown of academic impact, for papers by Leonard B. Johnson Breakdown of academic impact, for papers by Audrey N. Schuetz Breakdown of academic impact, for papers by Gary J. Noel Breakdown of academic impact, for papers by Roberto Luzzati Breakdown of academic impact, for papers by Frederick S. Nolte
Rankless by CCL
2026